High Flow Humidified Oxygen Delivery Device
Clinical application
It is often used clinically in patients with mild to moderate hypoxemia, such as hypoxic respiratory failure, such as ARDS, pneumonia, pulmonary fibrosis, and cardiogenic pulmonary edema. It has a positive therapeutic effect on patients with simple hypoxic respiratory failure (type I respiratory failure), and it may also have a certain therapeutic effect on patients with mild hypoxia and hypercapnia (type II respiratory failure), but it still needs more Confirmed by clinical studies of samples. If used in patients with moderate to severe hypoxemia, close monitoring of the clinical deterioration that may lead to intubation is required.
Main Feature
1. Provide a stable high oxygen concentration, quickly and effectively improve blood oxygen.
2. Flush the dead space of physiological anatomy, reduce carbon dioxide and then inhale.
3. Form a certain positive airway pressure to keep the airway open.
4. Reduce the patient's upper airway resistance and work of breathing to improve the patient's ventilation and partial ventilation function.
5. Adequate humidification and warming make the airway mucus and cilia cleaning function in the best condition.
6. Comfortable user experience, improve compliance.
Clinical application value
1. ICU emergency mild and moderate acute respiratory failure(hypoxic Non-CO2 retention )
Improve breathing difficulty and the effect of improving oxygenation is obvious.
The rate of intubation and mortality were significantly lower than that of noninvasive ventilation and standard oxygen therapy.
2. A new option from the creative withdrawal machine.
The drone fights and reduces the reintubation rate.
3. Acute heart failure or cardiogenic pulmonary edema
Improve oxygenation and reduce cardiac load.
4. Hypoxic patients assist bronchoscopy, transesophageal ultrasonography and digestive endoscopy.
Added an effective oxygen therapy.
5. Chronic respiratory failure
Improve ciliary activity, promote sputum discharge, reduce the chance of infection.
6. Palliative treatment
New options for end-stage patients who reject intubation and resuscitation.
7. Cardiothoracic surgery is associated with a risk of respiratory failure.
The results were comparable to non-invasive ventilation, but the patient was comfortable.
Consumable Accessories
Humidification pot for homecare One water injection can last for 3-10 hours
Model | HUMID-BHR |
Power supply | 220VAC+22V,50+1Hz |
Flow setting range | ●High Flow Mode:10-60L/Min |
Temperature Control | 31°C ,34°C ,37°C |
Oxygen% Measure | 21 %-50% |
FiO2 Control | Manual titration control |
Alarm parameters | ●Low oxygen concentration alarm ●High oxygen concentration alarm ●Ambient temp alarm ●Choke alarm ●Alarm recovery |
Recommended Ambient Temp | 18-28°C |
Standards | IEC/EN 6060-1, IEC/ EN 60601-1-2; IS08185 |
Package | L330xW245xH315mm |
Application | HOME CARE |
Our Company
Shenyang Maisi Medical Technology Co., Ltd. is a high-tech emerging modern enterprise specializing in the development, production, sales and service of respiratory diagnosis and treatment and electronic products. It is a domestic company with core technology covering 2 major respiratory therapy equipment.
The company is headquartered in Hunnan High-tech Development Zone, Shenyang City, Liaoning Province. The company covers an area of more than 6000 square meters. The current main products are high-flow respiratory humidification therapy equipment (HFNC), non-invasive ventilation therapy equipment (BiPAP AutoBiPAP and Auto-CPAP) . The company's products have passed the US FDA, EU CE, RoHS and South Korea GMP certification, and strictly implement ISO13485, ISO9001 and national and industry related standards in every link of development and production. The product quality is stable and reliable, and has been universally recognized by customers all over the world.
The company's technical core backbone is composed of a team of technical experts from the fields of domestic information technology, automation control, machinery manufacturing and medical technology. The company has good cooperation with Air Force Aviation Medical Research Institute, China Medical University and other well-known domestic units.
Since its founding, Maxx Medical has forged ahead and has become a brand influential enterprise in the field of respiratory support in China. To create the future and not forget the original intention, Max Medical will strive to become an excellent brand of respiratory support in China.
Maisi has many years of experience in product development in the respiratory therapy industry, and has won a number of patents. The perfect after-sales service has brought us more and more users and sold to more than a dozen countries and regions. Based on the principle of good quality and customer first, we will dedicate effective and reliable products to customers with superb and innovative technical strength, advanced equipment and good service attitude.
Use advanced technology to serve clinical respiratory medicine and seek welfare for patients with respiratory diseases.
With professional integrity, we provide advanced, convenient and economical sleep and breathing treatment programs for patients with respiratory diseases.
FAQ
1. Are you a manufacturer or trading company?
RE:We are a manufacturer specilized in respirtory products,including Noninvasive Ventilators, HFNC and Oxygen Concentrators.
2. Do you have any certification?
RE:We are CE and EN ISO 13485 approved and FDA is in application and will be available in near future.
3. How long is your product warranty period?
RE:2 years.